Macralytics CMS
Home
MIPS Measures
Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)
Written by
in
←
RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer Who Receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3 Days (lower score – better)
→
More posts
Quality Payment Program (QPP): Complete Guide
June 12, 2026